Similarly, in GBM tumor masses, the predominant presence of neutrophilic (CD33+CD15+CD14−HLA-DR−) and negative lineage (CD33+CD15−CD14−HLA-DR−) MDSCs has been shown [17,24]. This evidence concerns the gene CD33 and neoplasm.